359 related articles for article (PubMed ID: 11703284)
21. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
Lin YC; Wu MY; Li DR; Wu XY; Zheng RM
World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291
[TBL] [Abstract][Full Text] [Related]
22. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
23. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
Berger F; Geddert H; Faller G; Werner M; Dimmler A
Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
[TBL] [Abstract][Full Text] [Related]
24. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines.
Mialhe A; Levacher G; Champelovier P; Martel V; Serres M; Knudsen K; Seigneurin D
J Urol; 2000 Sep; 164(3 Pt 1):826-35. PubMed ID: 10953163
[TBL] [Abstract][Full Text] [Related]
25. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
[TBL] [Abstract][Full Text] [Related]
26. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.
Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ
Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342
[TBL] [Abstract][Full Text] [Related]
27. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
28. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
29. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease.
Karayiannakis AJ; Syrigos KN; Efstathiou J; Valizadeh A; Noda M; Playford RJ; Kmiot W; Pignatelli M
J Pathol; 1998 Aug; 185(4):413-8. PubMed ID: 9828841
[TBL] [Abstract][Full Text] [Related]
30. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
32. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
Davies BR; Worsley SD; Ponder BA
Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220
[TBL] [Abstract][Full Text] [Related]
33. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
34. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
35. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer.
Miyamoto S; Baba H; Kuroda S; Kaibuchi K; Fukuda T; Maehara Y; Saito T
Br J Cancer; 2000 Nov; 83(9):1168-75. PubMed ID: 11027430
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin and catenins in early squamous cervical carcinoma.
Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
[TBL] [Abstract][Full Text] [Related]
37. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.
Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
Thyroid; 1999 Nov; 9(11):1095-103. PubMed ID: 10595458
[TBL] [Abstract][Full Text] [Related]
38. Expression status of E-cadherin and alpha-, beta-, and gamma-catenins in thymoma.
Yoshino I; Kase S; Yano T; Sugio K; Sugimachi K
Ann Thorac Surg; 2002 Mar; 73(3):933-7. PubMed ID: 11899204
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.
Alami J; Williams BR; Yeger H
Mol Pathol; 2003 Aug; 56(4):218-25. PubMed ID: 12890743
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
